Palmoplantar pustulosis: pathogenesis, differential diagnosis, and treatment. [PDF]
Mössner R +5 more
europepmc +1 more source
Dyshidrotic Eczema Mimicking Palmoplantar Pustulosis During Apremilast Treatment: A Diagnostic Pitfall. [PDF]
Yatsuzuka K +3 more
europepmc +1 more source
Paradoxical Cutaneous Reaction: Secukinumab-Associated PLEVA in Palmoplantar Pustulosis. [PDF]
Liu W, Chen Y, Lin Z, Zhang J, Li C.
europepmc +1 more source
Clinical and immunomicrobiome correlates of a standardized Qingpao Chushi Jiedu Fang regimen in palmoplantar pustulosis. [PDF]
Wang J, Yang Y, Chen Z.
europepmc +1 more source
IL-4Rα antagonist (Stapokibart) in refractory palmoplantar pustulosis: a case report and literature review of Th2-targeted therapies. [PDF]
Zhang Y +5 more
europepmc +1 more source
Paradoxical palmoplantar pustulosis induced by secukinumab in a patient with hidradenitis suppurativa. [PDF]
Alkhamis RS +4 more
europepmc +1 more source
Danyang Fan, Fuqiu Li, Zhe Liu, Zhanhan Tang, Sha Lv Department of Dermatology, The Second Hospital of Jilin University, Changchun, Jilin, 130000, People’s Republic of ChinaCorrespondence: Sha Lv, Department of Dermatology, The second hospital of Jilin ...
Fan D, Li F, Liu Z, Tang Z, Lv S
doaj
Evaluation of Diabetes Mellitus, Hyperlipidemia, and Thyroid Disease Comorbidities in Palmoplantar Pustulosis. [PDF]
Akbaş A +3 more
europepmc +1 more source
Successful Treatment of Refractory Palmoplantar Pustulosis With Bimekizumab in a Patient With Multiple Sclerosis: A Case Report. [PDF]
Mahboob O +4 more
europepmc +1 more source
Tofacitinib for the treatment of palmoplantar pustulosis: A multicenter prospective study. [PDF]
Tao Y +10 more
europepmc +1 more source

